PDC*line Pharma presents at the Sachs 16th Annual Biotech in Europe forum
PDC*line Pharma receives Advanced-Therapy Medicinal Product (ATMP) classification from the European Medicines Agency (EMA) for its new class of therapeutic cancer vaccines (PDC*vac)
June 15th 2015 –...
From right to left: Isabelle Tabah-Fisch (CMO), Laurent Levy (CEO) and Joel Plumas...
PDC*line Pharma received €500 k in grants and won 3 awards in 2014: the Worldwide Innovation Challenge 2030, the i-Lab French competition, and the French plan “medical biotechs”.
PDC*line Pharma was selected for the Medical Biotechnology industrial plan.
Article
A reception has taken place at the Elysee Palace for the 110 award recipients of the Worldwide Innovation Challenge 2030.
Article
PDC*line pharma has been declared as a national winner of the 2014 edition of the French competition for creation of innovative companies, in the “creation – development” category.
PDC*line Pharma has been selected to present at Biovision Investor Conference on June 5, 2014.
